New Medicine Could Reduce Infant RSV Hospitalisations
Sanofi announced that the South African Health Products Regulatory Authority (SAHPRA) has granted registration for a long-acting monoclonal antibody (mAb) …
New Medicine Could Reduce Infant RSV Hospitalisations Read More